Please login to the form below

Not currently logged in
Email:
Password:

Open Access Consulting appoints new director

Jayne Hurrell joins the group from Evidera

Jayne HurrellOpen Access Consulting, part of the Open Health Group, has appointed Jayne Hurrell into the newly created role of director of global value communications.

Hurrell joins the group from Evidera, where she worked for over a decade, most recently as vice president and EU practice lead, market access communications.

In this role, Hurrell oversaw the team’s market access communications offering, supporting clients in the development of value communications materials with the payer as the ultimate end audience, including core value dossiers, payer-focused objection handlers, stand-alone payer value propositions and local HTA submissions.

With a background in medical writing, Hurrell combines strategic expertise and insights into the payer perspective with a focus on high-quality outputs that provide compelling value messages underpinned by supporting evidence.

Commenting on the appointment, Dorinda Hickey, CEO of Open Access Consulting, said: “We are delighted to have Jayne on board.

“Our global value communications team has grown significantly over the last year and will really benefit from her expertise and leadership.”

13th April 2018

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

We love what we do and we think it shows.It shows in the work we do, the space we work...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics